Neurodegeneration onset with glucagon-like peptide-1 receptor agonists in people with type 2 diabetes: a real-world multinational cohort study | Cardiovascular Diabetology
In a multinational, retrospective cohort study of 214,442 people living with type 2 diabetes without evidence of neurodegenerative disorders, the initiation of GLP-1 RAs was associated with a 19% relative…